Humacyte Inc
Sector: Manufacturing
Industry: Pharmaceutical Products
1.32
0.13
(10.92%)
Volume:
4,445,836
52 week range:
1.15 - 9.97
Market Cap:
204.757M
Company Description:
Humacyte, Inc. engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues. Its investigational HAVs are designed to be easily implanted into any patient without inducing a foreign body response or leading to immune rejection. The company was founded in 2004 and is headquartered in Durham, North Carolina.